For many women, the truest threat of menopause happens out of sight. Medical experts at the 18th Asian-Pacific Society of ...

Patients in London have received a pioneering new gene editing therapy that lowers "bad" cholesterol after a single infusion, ...

Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...

For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the treatment menu has been frustratingly short: a modest pill called ezetimibe ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Phase 1 clinical data poster selected as a Best of EASL 2026 presentationCombination of denifanstat and resmetirom was generally well-tolerated ...

In high-risk patients without prior heart attack or stroke who underwent percutaneous coronary intervention, evolocumab ...

Cardiovascular disease (CVD) remains the leading cause of death in the Philippines, driven largely by atherosclerosis and delayed treatment. Health experts are now urging earlier and more aggressive ...

Very high levels are even more dangerous than better-known risks for heart-attack and stroke. “In individuals who don’t have heart disease, it seems it is equivalent to having two other modifiable ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company developing transformative medicines for serious diseases, shared new preclinical ...